HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

One-year results of semiconductor transscleral cyclophotocoagulation in patients with glaucoma.

Abstract
We evaluated 30 consecutive patients with glaucoma treated with semi-conductor diode transscleral cyclophotocoagulation to determine the results and complications of this procedure. Twelve months after surgery the mean (+/- SD) preoperative intraocular pressure of 32.5 +/- 10.9 mm Hg (n = 30) had dropped to 20.8 +/- 15.6 mm Hg (n = 19) (P = .018, paired Student's t test), while the mean number of preoperative medications received decreased from 2.0 to 1.8 (P = .060, Wilcoxon's Signed Rank Test). One year after surgery three patients (10%) were unavailable for follow-up, eight (27%) had required other surgical procedures to control the intraocular pressure, 17 (56%) had controllable intraocular pressure of 21 mm Hg or below or received pain relief from the diode laser alone, and two (7%) patients with controlled intraocular pressure had suffered visual loss. Other complications included mild conjunctival hyperemia and uveitis in all patients and mild ocular pain in six patients. This study suggests the usefulness of diode transscleral cyclophotocoagulation in reducing the intraocular pressure for up to 1 year.
AuthorsT A Hawkins, W C Stewart
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 111 Issue 4 Pg. 488-91 (Apr 1993) ISSN: 0003-9950 [Print] United States
PMID8470980 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Ciliary Body (surgery)
  • Female
  • Follow-Up Studies
  • Glaucoma (surgery)
  • Humans
  • Intraocular Pressure
  • Laser Coagulation (methods)
  • Male
  • Middle Aged
  • Postoperative Complications
  • Prognosis
  • Sclera
  • Semiconductors
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: